van Houtum, Lisanne A. E. M.
Baaré, William F. C.
Beckmann, Christian F.
Castro-Fornieles, Josefina
Cecil, Charlotte A. M.
Dittrich, Juliane
Ebdrup, Bjørn H.
Fegert, Jörg M.
Havdahl, Alexandra
Hillegers, Manon H. J.
Kalisch, Raffael
Kushner, Steven A.
Mansuy, Isabelle M.
Mežinska, Signe
Moreno, Carmen
Muetzel, Ryan L.
Neumann, Alexander
Nordentoft, Merete
Pingault, Jean-Baptiste
Preisig, Martin
Raballo, Andrea
Saunders, John
Sprooten, Emma
Sugranyes, Gisela
Tiemeier, Henning
van Woerden, Geeske M.
Vandeleur, Caroline L.
van Haren, Neeltje E. M.
Funding for this research was provided by:
HORIZON EUROPE Framework Programme (101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529, 101057529)
Swiss State Secretariat for Education, Research and Innovation (22.00111, 101057529, 22.00170, 22.00170)
UK Research and Innovation (575067)
Article History
Received: 15 September 2023
Accepted: 15 March 2024
First Online: 13 April 2024
Declarations
:
: All studies included in the FAMILY framework have been approved by the respective local human research ethics committees and/or committees of animal experiments. All procedures performed in studies involving human participants are conducted in accordance with the ethical standards of the institutional and/or national research ethics committee and with the WMA Declaration of Helsinki and its latest amendments or comparable ethical standards. All animal experiments are conducted in full compliance with national/European Union directives on the protection of animals used for scientific purposes.
: BE is part of the Advisory Board of Eli Lilly Denmark A/S, Janssen-Cilag, Lundbeck Pharma A/S, and Takeda Pharmaceutical Company Ltd; and has received lecture fees from Bristol-Myers Squibb, Boehringer Ingelheim, Otsuka Pharma Scandinavia AB, Eli Lilly Company, and Lundbeck Pharma A/S. CM has received honoraria as a consultant and/or advisor and/or for lectures from Angelini, Compass, Esteve, Exeltis Janssen, Lundbeck, Neuraxpharm, Nuvelution, Otsuka, Pfizer, Servier and Sunovion. outside the submitted work. CFB is founder and shareholder of SBGneuro Ltd. Other authors have no competing interests to declare.